European Oncology Nursing Society extravasation guidelines

European Journal of Oncology Nursing

Volumn 12, Issue 4, 2008, Pages 357-361

  Wengstrom Y ^a   Margulies, A ^b  

^a UNIVERSITY OF STIRLING   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Evidence based practice; Extravasations; Vesicants

Indexed keywords

ANTINEOPLASTIC AGENT; IRRITANT AGENT;

ARTICLE; CONTRAST MEDIUM EXTRAVASATION; EUROPE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NURSING; PRACTICE GUIDELINE;

ANTINEOPLASTIC AGENTS; EUROPE; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; IRRITANTS;

EID: 50549089918     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2008.07.003     Document Type: Article

References (12)

1. Barlock A.L., Howser D.M., and Hubbard S.M. Nursing management of adriamycin extravasation. American Journal of Nursing 79 (1979) 94-96
2. Bertelli G., Gozza A., Forno G.B., et al. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. Journal of Clinical Oncology 13 (1995) 2851-2855
3. Ciliska D., Cullum D., and Marks. S. Evaluation of systematic reviews of treatment or prevention interventions. Evidence-Based Nursing 4 (2001) 100-104
4. European Oncology Nursing Society (EONS), 2007. Extravasation Guidelines 2007. EONS, Brussels, Belgium. Available at 〈http://www.cancerworld.org/CancerWorld/moduleStaticPage.aspx?id=38 91&id_sito=2&id_stato=1〉.
5. Langer S.W., Thougaard A.V., Sehested M., et al. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone. Cancer Chemotherapy and Pharmacology 57 (2006) 125-128
6. Langstein H.N., Duman H., Seelig D., et al. Retrospective study of the management of chemotherapeutic extravasation injury. Annals of Plastic Surgery 49 (2002) 369-374
7. Mader I., et al. Paravasation von Zytostatika-Kompendium für Prävention und Therapie. 2. Auflage (2006), Springer, Wien, New York
8. Mouridsen H.T., Langer S.W., Buter J., et al. Treatment of anthracycline extravasation with savene (dexrazoxane): results from two prospective clinical multicentre studies. Annals of Oncology 18 (2006) 546-550
9. Olver I.N., and Schwarz M.A. Use of dimethyl sulfoxide in limiting tissue damage caused by extravasation of doxorubicin. Cancer Treatment Reports 67 (1983) 407-408
10. Olver I.N., Aisner J., Hament A., et al. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. Journal of Clinical Oncology 6 (1988) 1732-1735
11. Sauerland C., Engelking C., and Wickham R.etal. Vesicant extravasation, Part I: Mechanisms, pathogenesis, and nursing care to reduce risk. Oncology Nursing Forum 33 (2006) 1134-1141
12. Schulmeister L. Extravasation management. Seminars in Oncology Nursing 23 (2007) 184-190